USA Scientists Awarded Research Grant

The National Institutes of Health has awarded a two-year, $423,500 grant to University of South Alabama (USA) scientists to conduct research on the amyloid precursor protein (APP) and its role in activating neutrophils to protect against bacterial infections. The principal investigators are Dr. Jonathon P. Audia, a professor of microbiology and immunology, and Dr. Robert A. Barrington, an associate professor of microbiology and immunology. The APP is best known for producing amyloid-beta, a key pathogenic molecule implicated in the development of Alzheimer’s disease and related dementias. However, there have been relatively few studies on the normal biological functions of APP, noted Audia. This research may also cast light on mechanisms underlying the long-term health problems faced by patients’ recovery after intensive care unit stays. Audia and Barrington said they previously made the exciting discovery that APP plays an important role in directing neutrophils during bacterial pneumonia.

Read More

Mathews To Headline First Regions Arena Event

Mathews To Headline First Regions Arena Event

Moore Coming To Saenger

Moore Coming To Saenger

Buffett Exhibit To Open September 12

Buffett Exhibit To Open September 12

ADCNR Awarded $7.1 Million To Improve Oyster Resilience

ADCNR Awarded $7.1 Million To Improve Oyster Resilience

ADCNR Hunter Education Classes Coming Up

ADCNR Hunter Education Classes Coming Up

Grants Accepted For Little Dauphin Island Restoration

Grants Accepted For Little Dauphin Island Restoration

Mobile Bay Inspiration Home Tours Continue Through August 30

Mobile Bay Inspiration Home Tours Continue Through August 30

Wilkins Miller Named A Top Accounting Firm To Work For

Wilkins Miller Named A Top Accounting Firm To Work For

Keesler Federal Battleship 12k To Be Held In November

Keesler Federal Battleship 12k To Be Held In November

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.